In this edition:
– Safety and tolerability of inclisiran in patients with hypercholesterolaemia
– Intravascular imaging, functional, or angiographically guided coronary intervention
– Educational attainment and lifetime risk of cardiovascular disease
– Impact of bempedoic acid on cardiovascular events
– Five-year follow-up after TAVI in low-risk patients
– Effect of dietary sodium on blood pressure
– Long-term outcomes of resynchronisation–defibrillation for heart failure
– Risk of severe QT prolongation with quetiapine and haloperidol
– Use of artificial intelligence to predict AF
– No increased risk of suicidal ideation with semaglutide
Download the Cardiology Research Review Issue 161, with commentary by A/Prof John Amerena

